1. Home
  2. CNTG

CNTG

Centogene N.V.

Logo Centogene N.V.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Founded: 2006 Country:
Germany
Germany
Employees: 517 City: N/A
Market Cap: 15.5M IPO Year: 2019
Target Price: $1.50 AVG Volume (30 days): 48.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.55 EPS Growth: N/A
52 Week Low/High: $0.55 - $2.52 Next Earning Date: 09-07-2023
Revenue: $55,723,077 Revenue Growth: 20.06%
Revenue Growth (this year): 4.47% Revenue Growth (next year): 22.37%

Share on Social Networks: